Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1CNS 1

Conditions

Breast Neoplasms 1461Neoplasms 987Colorectal Neoplasms 823Carcinoma, Non-Small-Cell Lung 714Carcinoma, Hepatocellular 680Stomach Neoplasms 644Lung Neoplasms 575Prostatic Neoplasms 539Pancreatic Neoplasms 451Rectal Neoplasms 334Uterine Cervical Neoplasms 303Neoplasm Metastasis 294Colonic Neoplasms 291Ovarian Neoplasms 281Recurrence 278Esophageal Neoplasms 273Leukemia, Myeloid, Acute 251Head and Neck Neoplasms 239Multiple Myeloma 231Brain Neoplasms 204Polycystic Ovary Syndrome 198Nasopharyngeal Carcinoma 197Melanoma 195Precursor Cell Lymphoblastic Leukemia-Lymphoma 192Urinary Bladder Neoplasms 189Lymphoma 177Liver Neoplasms 175Endometrial Neoplasms 158Motor Activity 142Lymphoma, Large B-Cell, Diffuse 140

Interventions

Rivaroxaban 1Long-Term Synaptic Depression 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × OTHER × Dyskinesias × Clear all
NCT06196918 2024-01-09

Efficacy and Safety of Rivaroxaban in the Prevention of Venous Thromboembolism in Glioma Patients

Nanfang Hospital, Southern Medical University

Phase NA Unknown
320 enrolled
CNSClassical hematology

Glioma, Dyskinesias, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡